Home/Healthcare/Biotechnology/North America Nuclear Medicine Market

North America Nuclear Medicine Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Growth and Trends Analysis By Applications (SPECT Market, PET Market), By Procedures (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary), By End-User Industry (Hospitals, Diagnostic Centers, Research Institutes), and Geography

Market Size in 2026
USD 8.28 billion
Market Size in 2031
USD 16.5 billion
CAGR
14.8%
Study Period
2021-2031
$3,250
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

πŸ“ž

Your data is secure. We do not share information with any third party.

Navigate

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061610987
PublishedMay 2026
Pages114
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

This report anticipates that the North America Nuclear Medicine Market will grow significantly over the forecast period, providing a comprehensive outlook up to the year 2022. It highlights major drivers, restraints, and opportunities to offer an exhaustive picture of the market's future trajectory. The analysis uses 2016 as its base year for projections.

The research study meticulously examines the North America Nuclear Medicine Market on the basis of various key segments. The report provides comprehensive forecasts for these specific segments, enabling stakeholders to understand the detailed market breakdown and performance across different areas within nuclear medicine.

Yes, the report presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments within North America. Furthermore, it analyzes the overall regulatory framework of the North American nuclear medicine market, offering stakeholders a better understanding of key factors affecting the market environment.

The report profiles several key industry players operating in the North America Nuclear Medicine Market. These include BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation, among others, providing insights into their market contributions.

This report provides an exhaustive picture of the North America Nuclear Medicine Market by detailing its major drivers, restraints, and opportunities. It also incorporates current market trends related to demand, supply, and sales, in addition to recent developments, to offer a complete understanding of the factors influencing the market's strategic direction.

The market size was determined by identifying key players and their revenue contributions through extensive secondary research, including industry associations and analyst reports. Both bottom-up and top-down approaches were utilized, with values correlated against primary inputs from C-Level Executives, Directors, and Managers across the value chain. Complete market engineering, using various data triangulation methods, was involved for market breakdown and forecasting.

Need data specifically for your business?Request Custom Research β†’
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon